Fluorescent in situ hybridization has limitations in screening NRG1 gene rearrangements
Abstract Background NRG1 fusion is a promising therapeutic target for various tumors but its prevalence is extremely low, and there are no standardized testing algorithms for genetic assessment. Mothods In this study, we analyzed 3008 tumors using Fluorescence in situ hybridization (FISH) and immuno...
Saved in:
Main Authors: | Xiaomei Zhang (Author), Lin Li (Author), Fuping Gao (Author), Binbin Liu (Author), Jing Li (Author), Shuang Ren (Author), Shuangshuang Peng (Author), Wei Qiu (Author), Xiaohong Pu (Author), Qing Ye (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Detection of ALK Gene Rearrangements in Non-Small Cell Lung Cancer by Immunocytochemistry and Fluorescence in Situ Hybridization on Cytologic Samples
by: Suneel RACHAGIRI, et al.
Published: (2022) -
Inv dup del(10q): Identification by fluorescence in situ hybridization and array comparative genomic hybridization in a fetus with two concurrent chromosomal rearrangements
by: Chih-Ping Chen, et al.
Published: (2012) -
Translational practice of fluorescence in situ hybridisation to identify neuroblastic tumours with TERT rearrangements
by: Yongbo Yu, et al.
Published: (2023) -
In vitro fertilization outcomes after preimplantation genetic testing for chromosomal structural rearrangements comparing fluorescence in-situ hybridization, microarray comparative genomic hybridization, and next-generation sequencing
by: Chantal B. Bartels, M.D, et al.
Published: (2020) -
HER 2 status in invasive breast cancer: Immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization
by: Hemlata S Shirsat, et al.
Published: (2012)